Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age.
Tapia MD, Findlow H, Idoko OT, Preziosi MP, Kulkarni PS, Enwere GC, Elie C, Parulekar V, Sow SO, Haidara FC, Diallo F, Doumbia M, Akinsola AK, Adegbola RA, Kampmann B, Chaumont J, Martellet L, Marchetti E, Viviani S, Tang Y, Plikaytis BD, LaForce FM, Carlone G, Borrow R. Tapia MD, et al. Among authors: marchetti e. Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S514-20. doi: 10.1093/cid/civ672. Clin Infect Dis. 2015. PMID: 26553683 Free PMC article. Clinical Trial.
Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adults.
Findlow H, Plikaytis BD, Aase A, Bash MC, Chadha H, Elie C, Laher G, Martinez J, Herstad T, Newton E, Viviani S, Papaspyridis C, Kulkarni P, Wilding M, Preziosi MP, Marchetti E, Hassan-King M, La Force FM, Carlone G, Borrow R. Findlow H, et al. Among authors: marchetti e. Clin Vaccine Immunol. 2009 Jul;16(7):969-77. doi: 10.1128/CVI.00068-09. Epub 2009 May 27. Clin Vaccine Immunol. 2009. PMID: 19474264 Free PMC article. Clinical Trial.
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.
Sow SO, Okoko BJ, Diallo A, Viviani S, Borrow R, Carlone G, Tapia M, Akinsola AK, Arduin P, Findlow H, Elie C, Haidara FC, Adegbola RA, Diop D, Parulekar V, Chaumont J, Martellet L, Diallo F, Idoko OT, Tang Y, Plikaytis BD, Kulkarni PS, Marchetti E, LaForce FM, Preziosi MP. Sow SO, et al. Among authors: marchetti e. N Engl J Med. 2011 Jun 16;364(24):2293-304. doi: 10.1056/NEJMoa1003812. N Engl J Med. 2011. PMID: 21675889 Free article. Clinical Trial.
Meningococcal group C and w135 immunological hyporesponsiveness in african toddlers.
Findlow H, Sow S, Borrow R, Tapia M, Haidara FC, Akinsola AK, Idoko OT, Diallo F, Adegbola R, Tang Y, Parulekar V, Chadha H, Mabey L, Holme D, Townsend K, Chaumont J, Laforce FM, Kulkarni PS, Marchetti E, Viviani S, Hassan-King M, Preziosi MP. Findlow H, et al. Among authors: marchetti e. Clin Vaccine Immunol. 2011 Sep;18(9):1492-6. doi: 10.1128/CVI.05020-11. Epub 2011 Jul 13. Clin Vaccine Immunol. 2011. PMID: 21752951 Free PMC article. Clinical Trial.
Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: a phase II/III double-blind randomized controlled trial.
Hirve S, Bavdekar A, Pandit A, Juvekar S, Patil M, Preziosi MP, Tang Y, Marchetti E, Martellet L, Findlow H, Elie C, Parulekar V, Plikaytis B, Borrow R, Carlone G, Kulkarni PS, Goel A, Suresh K, Beri S, Kapre S, Jadhav S, Preaud JM, Viviani S, LaForce FM. Hirve S, et al. Among authors: marchetti e. Vaccine. 2012 Oct 5;30(45):6456-60. doi: 10.1016/j.vaccine.2012.08.004. Epub 2012 Aug 13. Vaccine. 2012. PMID: 22898557 Clinical Trial.
Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate Vaccine.
Martellet L, Sow SO, Diallo A, Hodgson A, Kampmann B, Hirve S, Tapia M, Haidara FC, Ndiaye A, Diarra B, Ansah PO, Akinsola A, Idoko OT, Adegbola RA, Bavdekar A, Juvekar S, Viviani S, Enwere GC, Marchetti E, Chaumont J, Makadi MF, Pallardy F, Kulkarni PS, Preziosi MP, LaForce FM. Martellet L, et al. Among authors: marchetti e. Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S422-7. doi: 10.1093/cid/civ598. Clin Infect Dis. 2015. PMID: 26553670 Free PMC article. Review.
Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and Lessons.
Enwere GC, Paranjape G, Kulkarni PS, Ginde M, Hartmann K, Viviani S, Chaumont J, Martellet L, Makadi MF, Ivinson K, Marchetti E, Herve J, Kertson K, LaForce FM, Preziosi MP. Enwere GC, et al. Among authors: marchetti e. Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S501-6. doi: 10.1093/cid/civ509. Clin Infect Dis. 2015. PMID: 26553681 Free PMC article. Review.
Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years.
Diallo A, Sow SO, Idoko OT, Hirve S, Findlow H, Preziosi MP, Elie C, Kulkarni PS, Parulekar V, Diarra B, Cheick Haidara F, Diallo F, Tapia M, Akinsola AK, Adegbola RA, Bavdekar A, Juvekar S, Chaumont J, Martellet L, Marchetti E, LaForce MF, Plikaytis BD, Enwere GC, Tang Y, Borrow R, Carlone G, Viviani S. Diallo A, et al. Among authors: marchetti e. Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S521-30. doi: 10.1093/cid/civ518. Clin Infect Dis. 2015. PMID: 26553684 Free PMC article. Clinical Trial.
Immunogenicity and safety of a meningococcal a conjugate vaccine administered with routine EPI vaccines in African infants and toddlers.
Hodgson A, Haidara FC, Sow SO, Ansah PO, Ansah NA, Tapia MD, Bangre O, Enwere GC, Viviani S, Marchetti E, Montomoli E, Stanzani V, Tang Y, Plikaytis B, Parulekar V, Martellet L, Chaumont J, Makadi MF, Kulkarni PS, Carlone G, Borrow R, LaForce FM, Preziosi MP. Hodgson A, et al. Among authors: marchetti e. Vaccine. 2025 Oct 3;64:127698. doi: 10.1016/j.vaccine.2025.127698. Epub 2025 Sep 17. Vaccine. 2025. PMID: 40966979 Clinical Trial.
290 results